Holen Sie sich die Stockscreener-App
14.71
1.57%
-0.235
Handel nachbörslich:
14.71
0.005
+0.03%
Schlusskurs vom Vortag:
$14.94
Offen:
$15.16
24-Stunden-Volumen:
146.29K
Relative Volume:
0.82
Marktkapitalisierung:
$536.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.07%
1M Leistung:
+2.26%
6M Leistung:
-7.52%
1J Leistung:
-27.85%
1-Tages-Spanne:
$14.65
$16.41
1-Wochen-Bereich:
$14.09
$16.41
52-Wochen-Spanne:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
Firmenname
Rapport Therapeutics Inc
Sektor
Branche
Telefon
857-321-8020
Adresse
99 HIGH STREET, BOSTON
Vergleichen Sie RAPP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
14.71 | 545.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-08 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-07-02 | Eingeleitet | Jefferies | Buy |
| 2024-07-02 | Eingeleitet | Stifel | Buy |
| 2024-07-02 | Eingeleitet | TD Cowen | Buy |
Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten
Rapport Therapeutics Inc. stock prediction for this weekPortfolio Risk Summary & Real-Time Sentiment Analysis - Newser
Published on: 2025-08-15 16:33:54 - Newser
What data driven models say about Rapport Therapeutics Inc.’s futureEarnings Summary Report & Community Supported Trade Ideas - Newser
Chart based exit strategy for Rapport Therapeutics Inc.Weekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
How hedge fund analytics apply to Rapport Therapeutics Inc. stockTrade Performance Summary & Weekly High Potential Alerts - Newser
JonesTrading Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $42 - 富途牛牛
XTX Topco Ltd Buys Shares of 15,442 Rapport Therapeutics, Inc. (NASDAQ:RAPP) - Defense World
Q3 EPS Forecast for Rapport Therapeutics Cut by Analyst - Defense World
Can Rapport Therapeutics Inc. hit a new high this monthMarket Rally & Entry Point Confirmation Alerts - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsInflation Watch & Low Drawdown Investment Ideas - Newser
How to manage a losing position in Rapport Therapeutics Inc. [Profit Target]Risk Controlled Swing Trade Alerts - Newser
Will Rapport Therapeutics Inc. rebound enough to break evenFree Reliable Chart-Based Trade Entries - Newser
How to manage a losing position in Rapport Therapeutics Inc.Strategy Builder for Growth Focused Traders - Newser
Published on: 2025-08-12 06:02:16 - Newser
Why Rapport Therapeutics Inc. stock attracts strong analyst attentionSecure Asset Flow and Trend Pattern Analysis - Newser
What momentum shifts mean for Rapport Therapeutics Inc.Reversal Signal Prediction Based on Volume - Newser
Market reaction to Rapport Therapeutics Inc.’s recent newsTrade Safety Matrix for Conservative Traders - Newser
What Fibonacci levels say about Rapport Therapeutics Inc. reboundFree Multi-Bagger Potential Stock Forecast Tools - Newser
Intraday pattern recognizer results for Rapport Therapeutics Inc.Free Capital Protection Trading Strategies - Newser
Rapport Therapeutics Inc.’s volatility index tracking explainedMarket Downturn Defense Strategy Analysis - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayReal Time Trade Execution Alert Plan - Newser
Chart overlay techniques for tracking Rapport Therapeutics Inc.Short-Term Growth Watch with Signal Prediction - Newser
What is HC Wainwright’s Estimate for RAPP Q2 Earnings? - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at HC Wainwright - Defense World
Rapport Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Rapport Therapeutics' Q2 2025 Update: RAP-219's Precision Neuroscience Potential and September 2025 Catalyst - AInvest
Rapport (RAPP) Q2 Net Loss Widens 47% - AOL.com
Rapport Therapeutics reports Q2 EPS (75c), consensus (79c) - TipRanks
Rapport Therapeutics sees cash runway through end of 2026 - TipRanks
Rapport Therapeutics Reports Q2 2025 Financials and Business Update. - AInvest
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - GlobeNewswire
Press Release: Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - 富途牛牛
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
HC Wainwright Initiates Rapport Therapeutics at Buy With $31 Price Target - MarketScreener
Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)
Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):